Refine by
Disease Risk Technology
6 companies found
Technologybased inAustin, TEXAS (USA)
Natera is a global leader in cell-free DNA (cfDNA) testing, dedicated to oncology, women’s health, and organ health. We aim to make personalized genetic testing and diagnostics part of the standard of care to protect health and inform earlier, more ...
Renasight is a test to determine if there is a genetic cause for an individual’s kidney disease or if there is an increased hereditary risk due to family history. The test uses a blood or saliva sample to test ...
Technologybased inBoulder, COLORADO (USA)
We are developing a robust portfolio of human diagnostic tests internally and collaborate with commercial, academic and government partners. Our team consists of industry veterans, engineers and scientists with expertise in hardware and software ...
We are developing point-of-care, multiplex tests for host-response biomarkers in ...
Technologybased inHartford, CONNECTICUT (USA)
Oxitone is a pioneering digital continuous care model with its innovative AI-powered RPM solution that includes three patented innovations: an FDA-cleared wrist-sensor multi-parameter medical monitor and SaaS clinician’s portal powered by AI medical ...
Oxitone 1000M - World’s First FDA-cleared Wrist-Sensor Pulse Oximetry Monitor; No fingertip probe, Bluetooth, Rechargeable long life battery., Wearable, easy to use, FDA-cleared, CE Mark ...
Technologybased inNeve Ilan, ISRAEL
We have developed a digital X-ray source enabling a cost reduction of medical imaging systems by orders of magnitude. We are a global company planning mass deployment of imaging systems. Our goal is to drive early detection preventive healthcare as ...
Healthcare providers and payers can now benefit from AI medical imaging technology to screen for early signs of chronic disease in large populations. Nanox Ai enables more accurate risk-adjustment so patients are ...
Technologybased inLondon, UNITED KINGDOM
Founded in 2015, the original idea behind Airfinity was to systematically capture and structure the new science disseminated at conferences, a highly fragmented dataset. However, through working with medical associations and pharma companies, ...
The world’s most comprehensive biorisk surveillance solution, providing real-time alerts and analysis on emerging outbreaks and infectious disease risks. ...
Technologybased inAbingdon, UNITED KINGDOM
Thermally Stable Needle Free Solid Dose Vaccines. Enesi Pharma is developing next-generation vaccination products targeting infectious diseases and emergent threat pathogens enabled by its ImplaVax technologies. These diseases affect millions of ...
